Is prolongation of corrected QT interval associated with seizures induced by electroconvulsive therapy reduced by atropine sulfate?

Pacing Clin Electrophysiol. 2017 Nov;40(11):1246-1253. doi: 10.1111/pace.13188. Epub 2017 Oct 6.

Abstract

Background: Electrocardiogram abnormalities have been reported during electroconvulsive therapy (ECT). A corrected QT interval (QTc) prolongation indicates delayed ventricular repolarization, which can trigger ventricular arrhythmias such as torsade de pointes (TdP). We examined the QTc changes during generalized tonic-clonic seizures induced by ECT, and the effects of atropine sulfate on these QTc changes.

Methods: We analyzed heart rate, QT interval, and QTc in 32 patients with depression who underwent ECT (25 women, 67.4 ± 8.7 years of age). The QTc from -30 to 0 seconds prestimulation was used as baseline, which was compared with QTc at 20-30 seconds and 140-150 seconds poststimulus onset.

Results: QTc was significantly prolonged at 20-30 seconds poststimulus, then significantly decreased at 140-150 seconds poststimulus, compared with baseline. QTc prolongation induced by ECT was significantly decreased by atropine sulfate.

Conclusions: These data suggest that the risk of TdP may be enhanced by ECT. Further, the risk of cardiac ventricular arrhythmias, including TdP, may be reduced by administration of atropine sulfate.

Keywords: QT interval; atropine sulfate; corrected QT interval (QTc); electroconvulsive therapy (ECT); heart rate (HR).

MeSH terms

  • Aged
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atropine / therapeutic use*
  • Bipolar Disorder / therapy
  • Depressive Disorder, Major / therapy
  • Electrocardiography
  • Electroconvulsive Therapy / adverse effects*
  • Electroencephalography
  • Female
  • Heart Rate
  • Humans
  • Long QT Syndrome / drug therapy*
  • Long QT Syndrome / physiopathology
  • Male
  • Risk Factors
  • Seizures / etiology
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents
  • Atropine